RANI

Rani Therapeutics Holdings Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 0/10
Rani Therapeutics Holdings sales and earnings growth
RANI Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 25.47%
  • FCF Y/Y↑ 30.06%
Rani Therapeutics Holdings gross and profit margin trends
RANI Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -2359.60%
  • ROIC 5Y↓ -51.37%
Rani Therapeutics Holdings net debt vs free cash flow
RANI Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.5
  • Interest coverage↓ -6.7

Rani Therapeutics Holdings stock volatility is higher than the overall market. We give it a Poor risk rating.

More Biotechnology stocks ↗